Supplementary materials: Cortistatin as a novel multimodal therapy for the treatment of Parkinson´s Disease
Supplementary materials: Cortistatin as a novel multimodal therapy for the treatment of Parkinson´s Disease
Supplementary Figure S1. Cortistatin protects against dopaminergic-related toxicity induced by MPTP. -- Supplementary Figure S2. Cortistatin preserves Bdnf expression in the acute model of MPTP. -- Supplementary Figure S3. Treatment with cortistatin reduces MPTP-induced nigral astrogliosis. -- Supplementary Figure S4. Cortistatin reduces MPTP-induced reactive microglia in the SNpc. -- Supplementary Figure S5. Cortistatin administration modulates microglia morphotypes in brain regions affected by MPTP. -- Supplementary Figure S6. Schematic representation of microglia-specific morphological prints. -- Table S1. Sequence of primers used for real-time PCR quantifications.
Peer reviewed
Neuroinflammation, Neurodegenerative diseases, Parkinson’s disease, Gliosis, Cortistatin
Neuroinflammation, Neurodegenerative diseases, Parkinson’s disease, Gliosis, Cortistatin
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!